Search

Your search keyword '"Dibs, Khaled"' showing total 30 results
Start Over Author "Dibs, Khaled"
30 results on '"Dibs, Khaled"'

2. Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial

Author

Kim, Sungjune, Wuthrick, Evan, Blakaj, Dukagjin, Eroglu, Zeynep, Verschraegen, Claire, Thapa, Ram, Mills, Matthew, Dibs, Khaled, Liveringhouse, Casey, Russell, Jeffery, Caudell, Jimmy J, Tarhini, Ahmad, Markowitz, Joseph, Kendra, Kari, Wu, Richard, Chen, Dung-Tsa, Berglund, Anders, Michael, Lauren, Aoki, Mia, Wang, Min-Hsuan, Hamaidi, Imene, Cheng, Pingyan, de la Iglesia, Janis, Slebos, Robbert J, Chung, Christine H, Knepper, Todd C, Moran-Segura, Carlos M, Nguyen, Jonathan V, Perez, Bradford A, Rose, Trevor, Harrison, Louis, Messina, Jane L, Sondak, Vernon K, Tsai, Kenneth Y, Khushalani, Nikhil I, and Brohl, Andrew S

Published
2022
Full Text
View/download PDF

3. Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort

Author

Issa, Majd, Klamer, Brett G., Mladkova, Nikol, Laliotis, Georgios I., Karivedu, Vidhya, Bhateja, Priyanka, Byington, Chase, Dibs, Khaled, Pan, Xueliang, Chakravarti, Arnab, Grecula, John, Jhawar, Sachin R., Mitchell, Darrion, Baliga, Sujith, Old, Matthew, Carrau, Ricardo L., Rocco, James W., Blakaj, Dukagjin M., and Bonomi, Marcelo

Published
2022
Full Text
View/download PDF

4. Immunoprofiles and Oncologic Outcomes of 15 Patients with Androgen Receptor-Positive Salivary Duct Carcinoma

Author

Gogineni, Emile, primary, Sells, Blake E., additional, Dibs, Khaled, additional, Jhawar, Sachin R., additional, Haring, Catherine T., additional, Limbach, Abberly L., additional, Konieczkowski, David J., additional, Ma, Sung J., additional, Zhu, Simeng, additional, Baliga, Sujith, additional, Mitchell, Darrion L., additional, Grecula, John C., additional, Bonomi, Marcelo, additional, Bhateja, Priyanka, additional, Old, Matthew O., additional, Seim, Nolan B., additional, Kang, Stephen Y., additional, Rocco, James W., additional, Chakravarti, Arnab, additional, Blakaj, Dukagjin M., additional, and Gamez, Mauricio E., additional

Published
2024
Full Text
View/download PDF

5. Palliative Quad Shot Radiation Therapy with or without Concurrent Immune Checkpoint Inhibition for Head and Neck Cancer

Author

Upadhyay, Rituraj, primary, Gogineni, Emile, additional, Tocaj, Glenis, additional, Ma, Sung J., additional, Bonomi, Marcelo, additional, Bhateja, Priyanka, additional, Konieczkowski, David J., additional, Baliga, Sujith, additional, Mitchell, Darrion L., additional, Jhawar, Sachin R., additional, Zhu, Simeng, additional, Grecula, John C., additional, Dibs, Khaled, additional, Gamez, Mauricio E., additional, and Blakaj, Dukagjin M., additional

Published
2024
Full Text
View/download PDF

6. Volumetric Modulated Arc Therapy Craniospinal Irradiation Utilizing a Vertebral Body Sparing Approach: An Alternative Approach to Improve Access and Minimize Toxicity

Author

Perlow, Haley K., primary, Matsui, Jennifer K., additional, Ewing, Ashlee, additional, Cadieux, Catherine, additional, Dibs, Khaled, additional, Upadhyay, Rituraj, additional, Blakaj, Dukagjin M., additional, Beyer, Sasha J., additional, Thomas, Evan M., additional, Grecula, John C., additional, Raval, Raju R., additional, and Palmer, Joshua D., additional

Published
2024
Full Text
View/download PDF

7. Scalp Irradiation with 3D-Milled Bolus: Initial Dosimetric and Clinical Experience

Author

Dibs, Khaled, primary, Gogineni, Emile, additional, Jhawar, Sachin M., additional, Baliga, Sujith, additional, Grecula, John C., additional, Mitchell, Darrion L., additional, Palmer, Joshua, additional, Haglund, Karl, additional, Andraos, Therese Youssef, additional, Zoller, Wesley, additional, Ewing, Ashlee, additional, Bonomi, Marcelo, additional, Bhateja, Priyanka, additional, Tinoco, Gabriel, additional, Liebner, David, additional, Rocco, James W., additional, Old, Matthew, additional, Gamez, Mauricio E., additional, Chakravarti, Arnab, additional, Konieczkowski, David J., additional, and Blakaj, Dukagjin M., additional

Published
2024
Full Text
View/download PDF

10. Vertebral Compression Fracture After Spine Stereotactic Body Radiotherapy: The Role of Vertebral Endplate Disruption

Author

Dibs, Khaled, primary, Facer, Benjin, additional, Mageswaran, Prasath, additional, Raval, Raju, additional, Thomas, Evan, additional, Gogineni, Emile, additional, Beyer, Sasha, additional, Pan, Jeff, additional, Klamer, Brett, additional, Ayan, Ahmet, additional, Bourekas, Eric, additional, Boulter, Daniel, additional, Fetko, Nicholas, additional, Cochran, Eric, additional, Zoller, Ian, additional, Chakravarthy, Vikram, additional, Tili, Esmerina, additional, Elder, J. Bradley, additional, Lonser, Russel, additional, Elguindy, Ahmed, additional, Soghrati, Soheil, additional, Marras, William, additional, Grecula, John, additional, Chakravarti, Arnab, additional, Palmer, Joshua, additional, and Blakaj, Dukagjin M., additional

Published
2023
Full Text
View/download PDF

12. Neoadjuvant Arterial Embolization of Spine Metastases Associated With Improved Local Control in Patients Receiving Surgical Decompression and Stereotactic Body Radiotherapy

Author

Damante, Mark A., primary, Gibbs, David, additional, Dibs, Khaled, additional, Palmer, Joshua D., additional, Raval, Raju, additional, Scharschmidt, Thomas, additional, Chakravarti, Arnab, additional, Bourekas, Eric, additional, Boulter, Daniel, additional, Thomas, Evan, additional, Grecula, John, additional, Beyer, Sasha, additional, Xu, David, additional, Nimjee, Shahid, additional, Youssef, Patrick, additional, Lonser, Russell, additional, Blakaj, Dukagjin M., additional, and Elder, J. Bradley, additional

Published
2023
Full Text
View/download PDF

13. Impact of Tobacco, Marijuana, and Alcohol use on Overall Survival in Recurrent Metastatic head and neck Cancer Patients Treated with Immune Checkpoint Inhibitors

Author

Alsavaf, Mohammad Bilal, primary, Issa, Majd, additional, Klamer, Brett G, additional, Husain, Marium, additional, Dibs, Khaled, additional, Pan, Xueliang, additional, Grecula, John C, additional, Old, Matthew O, additional, Konieczkowski, David, additional, Mitchell, Darrion L, additional, Baliga, Sujith, additional, Carrau, Ricardo L, additional, Rocco, James W, additional, Bonomi, Marcelo, additional, Blakaj, Dukagjin M., additional, and Bhateja, Priyanka, additional

Published
2023
Full Text
View/download PDF

14. Feasibility, safety, and efficacy of circumferential spine stereotactic body radiotherapy

Author

Dibs, Khaled, primary, Palmer, Joshua D., additional, Prasad, Rahul N., additional, Olausson, Alexander, additional, Bourekas, Eric C., additional, Boulter, Daniel, additional, Ayan, Ahmet S., additional, Cochran, Eric, additional, Marras, William S., additional, Mageswaran, Prasath, additional, Thomas, Evan, additional, Grecula, John, additional, Guiou, Michael, additional, Soghrati, Soheil, additional, Tili, Esmerina, additional, Raval, Raju R., additional, Mendel, Ehud, additional, Scharschmidt, Thomas, additional, Elder, James B., additional, Lonser, Russell, additional, Chakravarti, Arnab, additional, and Blakaj, Dukagjin M., additional

Published
2022
Full Text
View/download PDF

16. Spine Stereotactic Body Radiotherapy to Three or More Contiguous Vertebral Levels

Author

Dibs, Khaled, primary, Blakaj, Dukagjin M., additional, Prasad, Rahul N., additional, Olausson, Alexander, additional, Bourekas, Eric C., additional, Boulter, Daniel, additional, Ayan, Ahmet S., additional, Cochran, Eric, additional, Marras, William S., additional, Mageswaran, Prasath, additional, Thomas, Evan, additional, Lee, Hyeri, additional, Grecula, John, additional, Raval, Raju R., additional, Mendel, Ehud, additional, Scharschmidt, Thomas, additional, Lonser, Russell, additional, Chakravarti, Arnab, additional, Elder, James B., additional, and Palmer, Joshua D., additional

Published
2022
Full Text
View/download PDF

19. Postoperative Stereotactic Body Radiotherapy for Spinal Metastasis and Predictors of Local Control

Author

Blakaj, Dukagjin M, primary, Palmer, Joshua D, additional, Dibs, Khaled, additional, Olausson, Alexander, additional, Bourekas, Eric C, additional, Boulter, Daniel, additional, Ayan, Ahmet S, additional, Cochran, Eric, additional, Marras, William S, additional, Mageswaran, Prasath, additional, Katzir, Miki, additional, Yildiz, Vedat O, additional, Grecula, John, additional, Arnett, Andrea, additional, Raval, Raju, additional, Scharschmidt, Thomas, additional, Elder, James B, additional, Lonser, Russell, additional, Chakravarti, Arnab, additional, and Mendel, Ehud, additional

Published
2021
Full Text
View/download PDF

21. Sinonasal teratocarcinosarcoma: a therapeutic dilemma.

Author

Suarez, Geraldine Peralta, Dibs, Khaled, Carrau, Ricardo L., Schoenfield, Lynn, Blakaj, Dukagjin M., and Tinoco, Gabriel

Abstract

Sinonasal teratocarcinosarcomas (SNTCSs) are rare and aggressive malignant tumours with histological features of the three embryonic layers. They have an elevated local recurrence rate, risk of metastasis and mortality. Moreover, the therapeutic options are limited, and optimal management is not yet clear. As fewer than 150 cases have been reported, therapeutic strategies remain a clinical challenge. Here, we discuss a case of a large SNTCS successfully treated with surgical resection followed by concurrent chemotherapy and radiation. Despite the significant size of the tumour and the inferred high recurrence risk, the patient has had no recurrence over the past 45 months. Although the optimal treatment of SNTCS is not clearly outlined, the very limited data suggests that a multidisciplinary approach with surgery, radiation and chemotherapy is the best option for patients. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

22. Use of cetuximab added to weekly chemotherapy to improve progression-free survival in patients with recurrent metastatic head and neck squamous cell carcinoma after progression on immune checkpoint inhibitors.

Author

Issa, Majd, primary, Klamer, Brett, additional, Karivedu, Vidhya, additional, Bhateja, Priyanka, additional, Laliotis, Georgios I., additional, Dibs, Khaled, additional, Mladkova, Nikol, additional, Pan, Xueliang Jeff, additional, Old, Matthew O., additional, Gamez, Mauricio, additional, Grecula, John C., additional, Jhawar, Sachin R, additional, Mitchell, Darrion L, additional, Baliga, Sujith, additional, Carrau, Ricardo, additional, Rocco, James William, additional, Blakaj, Dukagjin, additional, and Bonomi, Marcelo Raul, additional

Published
2021
Full Text
View/download PDF

23. Expansion cohort validation of a clinical predictive model for head and neck cancer survival in patients treated with immune checkpoint inhibitors.

Author

Laliotis, Georgios I., primary, Issa, Majd, additional, Klamer, Brett, additional, Karivedu, Vidhya, additional, Bhateja, Priyanka, additional, Dibs, Khaled, additional, Mladkova, Nikol, additional, Pan, Xueliang Jeff, additional, Old, Matthew O., additional, Gamez, Mauricio, additional, Grecula, John C., additional, Jhawar, Sachin R, additional, Mitchell, Darrion L, additional, Baliga, Sujith, additional, Carrau, Ricardo, additional, Rocco, James William, additional, Blakaj, Dukagjin, additional, and Bonomi, Marcelo Raul, additional

Published
2021
Full Text
View/download PDF

25. Identification of Clinical and Socioeconomic Predictors of Adjuvant Therapy after Trans-Oral Robotic Surgery in Patients with Oropharyngeal Squamous Cell Carcinoma

Author

Baliga, Sujith, primary, Klamer, Brett, additional, Jhawar, Sachin, additional, Gamez, Mauricio, additional, Mitchell, Darrion, additional, Blakaj, Adriana, additional, Grecula, John, additional, Gardner, Ulysses, additional, Dibs, Khaled, additional, Old, Matthew, additional, Seim, Nolan, additional, Kang, Stephen, additional, Carrau, Ricardo, additional, Agrawal, Amit, additional, Karivedu, Vidhya, additional, Bhateja, Priyanka, additional, Ozer, Enver, additional, Rocco, James, additional, Bonomi, Marcelo, additional, and Blakaj, Dukagjin, additional

Published
2020
Full Text
View/download PDF

26. Volumetric-modulated arc therapy versus intensity-modulated radiotherapy for localized prostate cancer: a dosimetric comparative analysis of moderate hypofractionated radiation.

Author

Abu-Hijlih, Ramiz, Afifi, Shatha, Almousa, Abdelatif, Khader, Jamal, Alhajal, Wafa, AlRjoub, Ibrahim, Mheid, Sara, Asha, Wafa, Salah, Samer, Dibs, Khaled, Khatib, Sami, and Abuhijla, Fawzi

Subjects
VOLUMETRIC-modulated arc therapy, INTENSITY modulated radiotherapy, PROSTATE cancer, RADIATION, COMPARATIVE studies
Abstract

Aim: To compare Intensity Modulated Radiotherapy (IMRT) and Volumetric-Modulated Arc Radiotherapy (VMAT) for patients receiving moderate hypofractionated radiotherapy. Introduction: Hypofractionated radiation has been established for localized prostate cancer; however, eligibility for this treatment depends on strict dosimetric constraints. Methods: CT simulation datasets of 23 patients with localized prostate adenocarcinoma were analysed, IMRT and VMAT plans were generated for each patient. Dose Volume Histogram (DVH) records, Monitor Units (MUs), treatment delivery times, conformality, and homogeneity indices were compared between the two techniques. Hypofractionated regimen parameters were assessed for each technique to evaluate plan eligibility for the short-course radiotherapy (60 Gy over 20 fractions). Results: Compared with IMRT plans, VMAT resulted in better PTV coverage (p=0.001) and significantly decreased bladder and rectal (D50) doses (p=0.019 and p=0.002, respectively). Both conformality and homogeneity were improved with VMAT but did not reach statistical significance. The mean MUs were lower with VMAT than with IMRT (662 vs 738). Moreover, the treatment time was shorter with VMAT than with IMRT (mean, 1.8 vs 7.1 minutes, p=0.004). Four IMRT plans did not meet hypofractionated objectives and were deemed not eligible for short-course radiotherapy. All VMAT plans met the planning objectives. Conclusion: For hypofractionated prostate irradiation, VMAT resulted in improved PTV (D99) coverage and more sparing of surrounding tissues. VMAT used less MUs and shorter treatment time. VMAT could meet all constraints and made patients eligible for hypofractionated radiotherapy. Therefore, VMAT may be preferred for patients who undergo moderate hypofractionation scheme. [ABSTRACT FROM AUTHOR]

Published
2020

28. Pattern of blood count change during craniospinal irradiation and the effect on progression free survival in medulloblastoma adult patients.

Author

Dibs, Khaled Nabil, primary, Jaradat, Imad A., additional, Khader, Jamal, additional, Al Khairi, Laith, additional, Sarhan, Nasim, additional, Mohammad, Ahmad, additional, Sulaiman, Awf, additional, Amoudi, Mohammad, additional, Ismael, Yousef, additional, Hijlih, Ramiz, additional, Ghatasheh, Hamza, additional, and Al-Mousa, Abdelatif, additional

Published
2017
Full Text
View/download PDF

29. The impact of a one month palliative care rotation on medical residents working in a tertiary cancer center in Jordan.

Author

Shamieh, Omar M., primary, Alawneh, Alia, additional, Ahamd, Wafa, additional, Salmany, Sewar S, additional, Altamimi, Barakat, additional, Alkam, Hamzah, additional, Dibs, Khaled Nabil, additional, Mallah, Osama, additional, Ammar, Khawla, additional, Turfa, Rim, additional, Abdel-Razeq, Hikmat, additional, and Hui, David, additional

Published
2015
Full Text
View/download PDF

30. Volumetric Modulated Arc Therapy Craniospinal Irradiation Utilizing a Vertebral Body Sparing Approach: An Alternative Approach to Improve Access and Minimize Toxicity.

Author

Perlow HK, Matsui JK, Ewing A, Cadieux C, Dibs K, Upadhyay R, Blakaj DM, Beyer SJ, Thomas EM, Grecula JC, Raval RR, and Palmer JD

Abstract

Introduction: Craniospinal irradiation (CSI) is indicated for adult patients diagnosed with leptomeningeal disease (LMD). Proton-based vertebral body sparing (VBS) CSI has been explored with pediatric patients to minimize hematologic toxicity; however, utilization of VBS in an adult population is limited. A recent phase II trial has shown efficacy of proton-based CSI to treat non-small cell lung and breast cancer with LMD. We hypothesize that VBS CSI using volumetric modulated arc therapy (VMAT) could also effectively reduce dose to vertebral bodies and surrounding organs at risk, minimizing toxicity for adult patients with LMD and comparing favorably to proton-based CSI., Methods and Materials: Consecutive patients with LMD received VMAT VBS CSI, 30 Gy in 10 fractions, as a part of a prospective registry. Full VMAT arcs for the brain fields matched to 2 spine isocenters for the upper and lower spine were created using limited posterior arcs. To further decrease the vertebral body dose, an avoid entry and exit contour was created. Acute toxicity data were collected using Common Terminology Criteria for Adverse Events v5., Results: Ten adult patients were treated in this cohort. One patient experienced grade 2 neutropenia with the remaining 9 experiencing grade 1 hematologic toxicity. Three patients experienced grade 2 gastrointestinal toxicity with the remaining 7 experiencing grade 1 nausea. No patient experienced grade 3+ toxicities in this cohort. One patient experienced a 5-day delay in systemic therapy initiation due to neutropenia; otherwise, all patients planned for systemic therapy started without delay., Conclusions: In this study, VMAT VBS CSI led to acceptable toxicity compared with patients treated with proton CSI on a phase 2 clinical trial. Given its promising early results, future prospective evaluation of the technique is warranted., (© 2023 The Author(s).)

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results